CTOs on the Move

Gen-Diagnostics

www.gen-dia.com

 
Gen-Diagnostics Incorporated is a San Juan Capistrano, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.gen-dia.com
  • 27132 Paseo Espada
    San Juan Capistrano, CA USA 92675
  • Phone: 800.497.1319

Executives

Name Title Contact Details

Similar Companies

Particle Health

Particle Health is on a mission to solve the biggest problem facing the American healthcare system - data sharing.

Greenway Health

Improving health is at the heart of Greenway Health`s work. We connect providers to the right information and insights, at the right place and time, so they can make patient-driven care a reality while navigating the ever-changing healthcare system. Greenway delivers exceptional service through a deep team of clinical, financial, and technology experts committed to innovations that keep people healthier and happier. We partner with over 8,000 organizations and 75,000 progressive providers across more than 40 specialties, which translates into more than 100 million lives that are touched by our solutions. All of Greenway Health`s solutions and services are designed to meet our company-wide goals of serving physicians, connecting the industry, and empowering better care. Whether as a customer, strategic partner, or staff member, you are invited to partner with us to create a smarter healthcare system.

Blue Cross and Blue Shield of Minnesota

Blue Cross and Blue Shield of Minnesota is a taxable, nonprofit organization with a mission to make a healthy difference in people’s lives. Chartered in 1933 as Minnesota’s first health plan, we’ve promoted wider, more economical and timely availability of health services for the people of Minnesota for more than 75 years. A GOLD STANDARD HEALTH EMPLOYER Blue Cross was recently named a Gold Standard employer from the CEO Roundtable on Cancer from the American Cancer Society. We earned this award because we`re achieving the highest criteria for workplace programs that discourage tobacco use, encourage physical activity, promote healthy nutrition, support prevention and access to quality treatment

Sonrava Health

Sonrava Health is the parent organization of a national family of health and wellness companies, united by a singular dedication to delivering high-quality, convenient and affordable care through innovative provider models, health coverage and product offerings. Building on a proven platform of success, the brand will continue to expand access to dental and vision care with a mission of advancing whole-person health for patients from all backgrounds. A geographically diverse, multi-specialty organization with a unique mix of providers and payors, Sonrava Health is comprised of several companies – including Western Dental & Orthodontics, Western Dental Kids, Brident Dental & Orthodontics, Brident Dental Kids, LooksBrite Eye Centers, EyeMax Vision Plan, MIB Insurance Plans, Vital Smiles, MID-Atlantic Dental Partners, DentalWorks, and Perfect Teeth – all united in our commitment to quality, value and innovation in care.

TherOx

TherOx, Inc. (TherOx) is a private, venture-financed medical device company based in Irvine, California, dedicated to elevating the standard of care for treatment of heart attack patients. A heart attack is caused when an artery in the heart becomes blocked. Current treatment of heart attack is to reestablish blood flow in the blocked artery as quickly as possible. Typically, this is done with a combination of medication and a percutaneous coronary intervention (PCI) which may include the placement of a (intracoronary) stent. PCI successfully restores blood flow, but damage to the patient’s heart remains. Blood flow in the microvasculature downstream from the blockage is compromised, and critical heart muscle tissue is damaged – or infarcted – due to oxygen deprivation brought on by the heart attack. The intent of SuperSaturated Oxygen (SSO2) Therapy from TherOx is to salvage damaged heart tissue by placing a high concentration of oxygen (~760 – 1,000 mmHg, or 5 – 7 times normal levels) into the patient’s blood plasma and delivering it directly to the area impacted by the heart attack. SSO2 Therapy serves as a complement to PCI and stenting. Immediately following the interventional procedure, proprietary technology from TherOx mixes a pre-specified concentration of “SuperOxygenated” saline solution with the patient’s blood to produce SuperOxygenated blood. The SuperOxygenated blood is then delivered through a catheter to the oxygen deficient tissue. Company research has confirmed in clinical studies that SuperSaturated Oxygen Therapy has the potential to reverse ischemia and may resuscitate tissue that may otherwise die. SSO2 Therapy circulates the patient`s own blood via the existing arterial access site used for the stenting procedure. Thus, no new access site is required. The TherOx DownStream System and DownStream Cartridge bear the CE Mark but are not available for commercial distribution in the EU at this time.